What is Afon Technology?
Afon Technology is pioneering a novel approach to diabetes management through its innovative sensor technology. The device, worn on the underside of the wrist, utilizes low-power RF/microwave technology to provide real-time, non-invasive tracking and recording of blood glucose levels. This data is then relayed to a companion smart device application, offering a significant advancement over traditional monitoring methods and addressing a critical unmet need in the healthcare sector.
How much funding has Afon Technology raised?
Afon Technology has raised a total of $12.5M across 1 funding round:
Other Financing Round
$12.5M
Other Financing Round (2022): $12.5M, investors not publicly disclosed
What's next for Afon Technology?
The substantial enterprise-level funding indicates Afon Technology is poised for significant scaling and market penetration. This strategic investment will likely fuel further research and development, regulatory approvals, and the expansion of manufacturing capabilities. The company's focus on real-time, non-invasive monitoring positions it to capture a substantial share of the global diabetes care market, potentially transforming patient care and disease management.
See full Afon Technology company page
